138 related articles for article (PubMed ID: 1585278)
1. How rapid is the return of fertility after the use of Tri-Regol oral contraceptive?
Adám J
Ther Hung; 1992; 40(1):16-9. PubMed ID: 1585278
[TBL] [Abstract][Full Text] [Related]
2. Observations with a tri-phasic oral contraceptive (Tri-Regol) in everyday clinical practice.
Kovács I; Novák K; Pomázi L; Hammersberg E
Ther Hung; 1992; 40(2):86-9. PubMed ID: 1462283
[TBL] [Abstract][Full Text] [Related]
3. The relationship between vascular headaches and low-dose oral contraceptives.
Karsay K
Ther Hung; 1990; 38(4):181-5. PubMed ID: 2094059
[TBL] [Abstract][Full Text] [Related]
4. Use of triphasic Tri-Regol tablet in women of borderline age.
Takács G
Ther Hung; 1991; 39(4):188-91. PubMed ID: 1811332
[TBL] [Abstract][Full Text] [Related]
5. Contraception and therapy with Tri Regol tablet.
Adám J
Ther Hung; 1991; 39(2):75-7. PubMed ID: 1948781
[TBL] [Abstract][Full Text] [Related]
6. Examination of the rebound effect of biphasic oral contraceptives.
Kovács I
Ther Hung; 1990; 38(3):110-3. PubMed ID: 2284619
[TBL] [Abstract][Full Text] [Related]
7. Change to Tri-Regol from other oral contraceptives.
Garamvölgyi G
Ther Hung; 1991; 39(3):122-4. PubMed ID: 1818425
[TBL] [Abstract][Full Text] [Related]
8. [Advances in hormonal contraception. A new micro-pll with especially low hormone effect].
Gynakologe; 1994 Apr; 27(2 Suppl):1-12. PubMed ID: 9131064
[No Abstract] [Full Text] [Related]
9. Observations with Anteovin in relation to age.
Szigethy A
Ther Hung; 1991; 39(1):11-5. PubMed ID: 1858069
[TBL] [Abstract][Full Text] [Related]
10. Results of the multilateral study of Tri-Regol tablet.
Seregély G
Ther Hung; 1991; 39(3):136-41. PubMed ID: 1840164
[TBL] [Abstract][Full Text] [Related]
11. Clinical and endocrine effects of long-term hormonal contraception.
Balogh A
Acta Med Hung; 1986; 43(2):97-102. PubMed ID: 3588164
[TBL] [Abstract][Full Text] [Related]
12. [Clinical pharmacologic study of Tri-Regol tablets (new oral triphase contraceptives)].
Farkas M; Kovács L; Tasiné Tóth E
Acta Pharm Hung; 1990 May; 60(2-3):85-99. PubMed ID: 2117333
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
[TBL] [Abstract][Full Text] [Related]
14. A low-dose triphasic oral contraceptive.
Woutersz TB; Butler AJ; Cohen M; Korba VD; Canavan RC
Fertil Steril; 1987 Mar; 47(3):425-30. PubMed ID: 3556622
[TBL] [Abstract][Full Text] [Related]
15. Clinicopharmacological examination of Anteovin.
Farkas M; Szigethy A; Sas M
Ther Hung; 1987; 35(1):14-8. PubMed ID: 3438859
[TBL] [Abstract][Full Text] [Related]
16. Interaction of griseofulvin and oral contraceptives.
Côté J
J Am Acad Dermatol; 1990 Jan; 22(1):124-5. PubMed ID: 2298948
[No Abstract] [Full Text] [Related]
17. [Our experience in using the Hungarian biphasic systemic contraceptive anteovin].
Vasilev D; Katsarova M
Akush Ginekol (Sofiia); 1990; 29(2):78-81. PubMed ID: 2400066
[No Abstract] [Full Text] [Related]
18. [The clinico-pharmacological characteristics of anteovin].
Nikanorova SA; Kononova ES; Korkhov VV; Potin VV; Svechnikova FA; Boĭkova VV
Farmakol Toksikol; 1991; 54(1):30-1. PubMed ID: 1860494
[TBL] [Abstract][Full Text] [Related]
19. [Tri-Regol and its application in gynecological practice].
Marinov B; Kolarov G
Akush Ginekol (Sofiia); 2000; 39(3):56-7. PubMed ID: 11188001
[TBL] [Abstract][Full Text] [Related]
20. Results of a multilateral study with Anteovin.
Seregély G
Ther Hung; 1990; 38(4):160-5. PubMed ID: 2094055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
